Director, Head of Antibody Technology
Denne stilling er desværre ikke længere ledig.
Se alle ledige stillinger
Ballerup
Director, Head of Antibody Technology
Do you have a strong background in antibody technology, are you interested in immunology, immuno-oncology, and oncology, and do you have the expertise to guide a highly skilled and motivated team?
https://uhc.dk/wp-content/uploads/2023/08/Director_Head-of-Antibody-Technology.mp4
As Director, Head of Antibody Technology at Symphogen, you will have an essential purpose of providing daily operational and long-term strategic leadership for the Antibody Technology Department, currently a team of 15-18 highly skilled team members, securing high performance, strong team spirit and high engagement.
With direct report to Senior Vice President, Biologics Drug Design, Research.
Your main tasks include but are not limited to:
Management
Antibody Technology
Your qualifications are minimum a PhD and several years of postdoctoral research with documentation of excellent research work from the immuno-oncology field. Moreover, you have +5 years of relevant scientific experience within antibody technology and industrial drug development in biotech/pharma. This, ideally, includes experience with different antibody formats. Preferably, you also have 2-3 years of managerial experience, e.g., from relevant line and/or project team leadership roles. Experience with CRO collaboration is an advantage.
You are a person who brings professional pride and quality to the table and values great personal integrity. Also, you are self-driven, highly motivated with humor, and have a team player mindset. Finally, you thrive in a multi-faceted environment and enjoy working in teams with a collaborative approach to global cross-functional teams.
Symphogen offers a challenging job in a creative, goal-oriented, and value-based environment with a meaningful mission: to advance superior monoclonal antibody therapeutics to improve patients’ lives. You will be a part of a highly engaged and inspiring organization focusing on diversity, teamwork, commitment – and on you as a person.
Traveling: Limited travel, including visits to Servier Group (Paris, France, approx. 2-4 times per year).
Domicile: In a reasonable distance to the office in Ballerup.
For more details about the job or the company, please contact CEO Jørn Duhn, Unique Human Capital on M: +45 21 75 19 25. All applications must be in English and are treated confidentially.
Do you have a strong background in antibody technology, are you interested in immunology, immuno-oncology, and oncology, and do you have the expertise to guide a highly skilled and motivated team?
https://uhc.dk/wp-content/uploads/2023/08/Director_Head-of-Antibody-Technology.mp4
As Director, Head of Antibody Technology at Symphogen, you will have an essential purpose of providing daily operational and long-term strategic leadership for the Antibody Technology Department, currently a team of 15-18 highly skilled team members, securing high performance, strong team spirit and high engagement.
With direct report to Senior Vice President, Biologics Drug Design, Research.
Your main tasks include but are not limited to:
Management
- Provide daily operational leadership for the Antibody Technology Department
- Performance management, salary regulations, training, and talent development
- Ensure a high degree of cross-organizational communications, including towards the Servier R&D organization, to align team activities with overall company goals and needs
- Participate in budgeting and budget-follow-up activities as defined by the Finance Team
- Represent the department and Symphogen/Servier at scientific meetings with scientific presentations etc.
Antibody Technology
- Responsible for antibody discovery activities, including B-cell-derived antibody repertoire generation, transient protein expression and purification, immunogenicity risk prediction, antibody engineering, assay and process automation, biosensor core facility, bioinformatics, and next-generation sequencing
- Securing timely delivery of high-quality project deliverables and support to early platform innovation work
- Provide scientific and technical evaluations and recommendations to support Symphogen/Servier’s biologics technology and format strategy, including bispecific and domain antibodies as well as novel antibody discovery platforms to maintain a state-of-the-art antibody discovery platform
- Accountable for the implementation, maintenance, and supervision of appropriate procedures and guidelines to secure the optimal execution of tasks in the function, including for laboratory notebooks
Your qualifications are minimum a PhD and several years of postdoctoral research with documentation of excellent research work from the immuno-oncology field. Moreover, you have +5 years of relevant scientific experience within antibody technology and industrial drug development in biotech/pharma. This, ideally, includes experience with different antibody formats. Preferably, you also have 2-3 years of managerial experience, e.g., from relevant line and/or project team leadership roles. Experience with CRO collaboration is an advantage.
You are a person who brings professional pride and quality to the table and values great personal integrity. Also, you are self-driven, highly motivated with humor, and have a team player mindset. Finally, you thrive in a multi-faceted environment and enjoy working in teams with a collaborative approach to global cross-functional teams.
Symphogen offers a challenging job in a creative, goal-oriented, and value-based environment with a meaningful mission: to advance superior monoclonal antibody therapeutics to improve patients’ lives. You will be a part of a highly engaged and inspiring organization focusing on diversity, teamwork, commitment – and on you as a person.
Traveling: Limited travel, including visits to Servier Group (Paris, France, approx. 2-4 times per year).
Domicile: In a reasonable distance to the office in Ballerup.
For more details about the job or the company, please contact CEO Jørn Duhn, Unique Human Capital on M: +45 21 75 19 25. All applications must be in English and are treated confidentially.
Information og data
Denne ledige stilling har jobtypen "Afdelingsleder", og befinder sig i kategorien "Ledelse og personale".
Arbejdsstedet er beliggende i Ballerup.
Jobbet er oprettet på vores service den 29.8.2023, men kan have været deaktiveret og genaktiveret igen.
Dagligt opdateret: Dette job opdateres dagligt ud fra jobudbyderens hjemmeside via vores søgemaskineteknologi og er aktivt lige nu.
- Afdelingsleder
- Ballerup
Lignende jobs
-
Afdelingsleder i Greve
Fri kontaktSærligt Tilrettelagt Ungdomsuddannelse i Greve er et tilbud for unge med generelle indlæringsvanskeligheder, udviklingsforstyrrelse inden for autismespektret, ADHD og andet. Fælles for målgruppen er, at de alle har brug for et specialiseret uddannelsestilbud. Tilbuddet rummer op til 55 unge i aldersgruppen 16-25 år.Få mere info- Afdelingsleder
- Greve
-
Afdelingsleder i Greve
Fri kontaktPå Mosedeskolen står 730 elever, 80 medarbejdere samt forældre klar til at byde dig velkommen. Du vil blive en del af en traditionsrig og faglig stærk skole. Mosedeskolen har tre spor samt SFO og klub, og er en af ni folkeskoler i Greve. Skolen er velfungerende og eleverne klarer sig godt.Få mere info- Afdelingsleder
- Greve
-
Afdelingsleder i København K
Opportunity About usMaersk is a global leader in integrated logistics and have been industry pioneers for over a century. Through innovation and transformation we are redefining the boundarie..Få mere info- Afdelingsleder
- København K
Statistik over udbudte jobs som afdelingsleder i Ballerup
Herunder ser du udviklingen i udbudte afdelingsleder i Ballerup over tid. Bemærk at jobs der ikke har en bestemt geografi ikke er medtaget i tabellen. I den første kolonne ser du datoen. I den næste kolonne ser du det samlede antal afdelingsleder.
Se flere statistikker her:
Statistik over udbudte afdelingsleder over tid
| Dato | Alle jobs som afdelingsleder |
|---|---|
| 12. maj 2024 | 16 |
| 11. maj 2024 | 16 |
| 10. maj 2024 | 16 |
| 9. maj 2024 | 16 |
| 8. maj 2024 | 15 |
| 7. maj 2024 | 14 |
| 6. maj 2024 | 15 |
| 5. maj 2024 | 13 |
| 4. maj 2024 | 13 |
| 3. maj 2024 | 12 |
| 2. maj 2024 | 12 |
| 1. maj 2024 | 12 |
| 30. april 2024 | 12 |
| 29. april 2024 | 12 |
| 28. april 2024 | 11 |
| 27. april 2024 | 11 |
| 26. april 2024 | 11 |
| 25. april 2024 | 14 |
| 24. april 2024 | 16 |
| 23. april 2024 | 16 |
| 22. april 2024 | 15 |
| 21. april 2024 | 15 |
| 20. april 2024 | 17 |
| 19. april 2024 | 18 |
| 18. april 2024 | 17 |
| 17. april 2024 | 17 |
| 16. april 2024 | 17 |
| 15. april 2024 | 17 |
| 14. april 2024 | 17 |
| 13. april 2024 | 17 |
| 12. april 2024 | 16 |